No title
Mantle cell lymphoma (MCL) is an aggressive type of B-cell lymphoma with poor clinical outcome. The use of cytarabine (ara-C, cytosine analogue), a chemotherapeutic drug, in the treatment of MCL, has during the last decade greatly improved the survival rate in younger patients, but relapses are common and are often associated with drug resistance and poor outcome. The origin if resistance developm
